Literature DB >> 27489075

Mortality in people with intellectual disabilities in England.

G Glover1, R Williams2, P Heslop3, J Oyinlola2, J Grey3.   

Abstract

BACKGROUND: People with intellectual disabilities (IDs) die at younger ages than the general population, but nationally representative and internationally comparable mortality data about people with ID, quantifying the extent and pattern of the excess, have not previously been reported for England.
METHOD: We used data from the Clinical Practice Research Datalink database for April 2010 to March 2014 (CPRD GOLD September 2015). This source covered several hundred participating general practices comprising roughly 5% of the population of England in the period studied. General practitioner (GP) records identified people diagnosed by their GP as having ID. Linked national death certification data allowed us to derive corresponding mortality data for people with and without ID, overall and by cause.
RESULTS: Mortality rates for people with ID were significantly higher than for those without. Their all-cause standardised mortality ratio was 3.18. Their life expectancy at birth was 19.7 years lower than for people without ID. Circulatory and respiratory diseases and neoplasms were the three most common causes of death for them. Cerebrovascular disease, thrombophlebitis and pulmonary embolism all had standardised mortality ratios greater than 3 in people with ID. This has not been described before. Other potentially avoidable causes included epilepsy (3.9% of deaths), aspiration pneumonitis (3.6%) and colorectal cancer (2.4%). Avoidable mortality analysis showed a higher proportion of deaths from causes classified as amenable to good medical care but a lower proportion from preventable causes compared with people without ID. International comparison to areas for which data have been published in sufficient detail for calculation of directly standardised rates suggest England may have higher death rates for people with ID than areas in Canada and Finland, and lower death rates than Ireland or the State of Massachusetts in the USA.
CONCLUSIONS: National data about mortality in people with ID provides a basis for public health interventions. Linked data using GP records to identify people with ID could provide comprehensive population-based monitoring in England, unbiased by the circumstances of illnesses or death; to date information governance constraints have prevented this. However, GPs in England currently identify only around 0.5% of the population as having ID, suggesting that individuals with mild, non-syndromic ID are largely missed. Notably common causes of death suggest control of cardiovascular risk factors, epilepsy and dysphagia, management of thrombotic risks and colorectal screening are important areas for health promotion initiatives.
© 2016 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd.

Entities:  

Keywords:  England; cause of death; intellectual disability; international comparisons; life expectancy; mortality

Mesh:

Year:  2016        PMID: 27489075     DOI: 10.1111/jir.12314

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  37 in total

Review 1.  Health checks for adults with intellectual and developmental disabilities in a family practice.

Authors:  Ian Casson; Terry Broda; Janet Durbin; Angela Gonzales; Laurie Green; Elizabeth Grier; Yona Lunsky; Avra Selick; Kyle Sue
Journal:  Can Fam Physician       Date:  2018-04       Impact factor: 3.275

Review 2.  Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors:  Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal:  Ther Adv Drug Saf       Date:  2018-06-20

3.  Nursing care at end of life: a UK-based survey of the deaths of people living in care settings for people with intellectual disability.

Authors:  Ruth Northway; Stuart Todd; Katherine Hunt; Paula Hopes; Rachel Morgan; Julia Shearn; Rhian Worth; Jane Bernal
Journal:  J Res Nurs       Date:  2018-07-03

Review 4.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

5.  Cohort profile: Scotland's record-linkage e-cohorts of people with intellectual disabilities, and autistic people (SCIDA).

Authors:  Sally-Ann Cooper; Angela Henderson; Deborah Kinnear; Daniel Mackay; Michael Fleming; Gillian S Smith; Laura Anne Hughes-McCormack; Ewelina Rydzewska; Kirsty Dunn; J P Pell; Craig Melville
Journal:  BMJ Open       Date:  2022-05-13       Impact factor: 3.006

6.  Mental, Neurological, and Somatic Comorbidities and Their Treatment in Persons With Intellectual Disability.

Authors:  Markus Weih; Sabine Köhler; Norbert Schöll; Mandy Schulz; Ramona Hering
Journal:  Dtsch Arztebl Int       Date:  2022-06-17       Impact factor: 8.251

7.  Cause of death in adults with intellectual disability in the United States.

Authors:  S D Landes; J D Stevens; M A Turk
Journal:  J Intellect Disabil Res       Date:  2020-10-12

8.  The effect of low-trauma fracture on one-year mortality rate among privately insured adults with and without neurodevelopmental disabilities.

Authors:  Daniel G Whitney; Daniel Whibley; Karl J Jepsen
Journal:  Bone       Date:  2019-09-05       Impact factor: 4.398

Review 9.  The Medical Care of People With Intellectual Disability.

Authors:  Tanja Sappok; Albert Diefenbacher; Martin Winterholler
Journal:  Dtsch Arztebl Int       Date:  2019-11-29       Impact factor: 5.594

10.  Association of Intellectual Disability With All-Cause and Cause-Specific Mortality in Sweden.

Authors:  Tatja Hirvikoski; Marcus Boman; Magnus Tideman; Paul Lichtenstein; Agnieszka Butwicka
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.